Trial of An Innovative Smartphone Intervention for Smoking Cessation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02724462|
Recruitment Status : Active, not recruiting
First Posted : March 31, 2016
Last Update Posted : October 3, 2018
|Condition or disease||Intervention/treatment||Phase|
|Smoking||Behavioral: Smartphone-delivered Intervention (SmartQuit) Behavioral: : Smartphone-delivered Intervention (Standard of care app)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||2503 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Randomized Trial of An Innovative Smartphone Intervention for Smoking Cessation|
|Actual Study Start Date :||May 27, 2017|
|Actual Primary Completion Date :||September 28, 2018|
|Estimated Study Completion Date :||June 2019|
This is the experimental arm of the study. This includes receiving the novel/experimental smartphone smoking cessation app. Therapy description withheld to protect the integrity of the study.
Behavioral: Smartphone-delivered Intervention (SmartQuit)
The experimental arm includes an intervention using a novel smartphone smoking cessation app.
Active Comparator: Control
This is the control arm of the study. This includes receiving the standard of care smartphone smoking cessation app. Therapy description withheld to protect the integrity of the study.
Behavioral: : Smartphone-delivered Intervention (Standard of care app)
The control intervention uses a standard of care smartphone smoking cessation app.
- 30-day point prevalence abstinence [ Time Frame: 12 months post randomization ]No smoking in the past 30 days, as reported 12 month post treatment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02724462
|United States, Washington|
|Fred Hutchinson Cancer Research Center|
|Seattle, Washington, United States, 98109|
|Principal Investigator:||Jonathan Bricker, Ph.D.||Fred Hutchinson Cancer Research Center|